Stryker Is Maintained at Overweight by Wells Fargo
Stryker Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Stryker, Raises Price Target to $381
Wells Fargo analyst Larry Biegelsen maintains Stryker with a Overweight and raises the price target from $364 to $381.
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Stryker Corporation
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $350 from
Stryker Corporation (NYSE:SYK) Q1 2024 Earnings Call Transcript
Stryker (SYK) Gets a Buy From Piper Sandler
Stryker Shares Are Trading Lower Despite Better-than-expected Q1 Earnings.
Stryker Shares Are Trading Lower Despite Better-than-expected Q1 Earnings.
Piper Sandler: Maintain the Stryker (SYK.US) rating and adjust the target price from $375.00 to $380.00.
Piper Sandler: Maintain the Stryker (SYK.US) rating and adjust the target price from $375.00 to $380.00.
Stryker Price Target Raised to $369.00/Share From $366.00 by BTIG
Stryker Price Target Raised to $369.00/Share From $366.00 by BTIG
Wells Fargo Adjusts Price Target on Stryker to $381 From $364
Stryker (SYK) has an average rating of outperform and price targets ranging from $242 to $406, according to analysts polled by Capital IQ. Price: 333.72, Change: -2.78, Percent Change: -0.83
Stryker Is Maintained at Outperform by Baird
Stryker Is Maintained at Outperform by Baird
Baird Maintains Outperform on Stryker, Raises Price Target to $378
Baird analyst Jeff Johnson maintains Stryker with a Outperform and raises the price target from $367 to $378.
Needham: Reiterates that Stryker (SYK.US) holds the rating.
Needham: Reiterates that Stryker (SYK.US) holds the rating.
Needham Reiterates Hold on Stryker
Needham analyst Mike Matson reiterates Stryker (NYSE:SYK) with a Hold.
Stryker Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 — Needham Reiterates → Hold 04/15/2024 14.2% RBC Capital $360 → $386 Maintains Outperform 04/1
Earnings Call Summary | Stryker Corp(SYK.US) Q1 2024 Earnings Conference
The following is a summary of the Stryker Corporation (SYK) Q1 2024 Earnings Call Transcript:Financial Performance:Stryker experienced substantial organic sales growth of 10% with key growth in MedSur
Stryker Corp (SYK) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Optimistic ...
Stryker Lifts 2024 Profit Forecast on Strong Demand for Medical Devices, Implants
Stryker Corp (SYK) Q1 2024 Earnings: Adjusted EPS Exceeds Analyst Expectations
Stryker Corp. Q1 Profit Increases, Beats Estimates
Stryker's Q1 Adjusted EPS, Sales Increase; 2024 EPS Guidance Boosted; Shares Drop After Hours
Stryker (SYK) reported Q1 adjusted earnings late Tuesday of $2.50 per diluted share, up from $2.14 a year earlier. Analysts polled by Capital IQ expected $2.36. Net sales in the quarter ended March 31
No Data